Gene Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
Entrez Id: 10162
Gene Symbol: LPCAT3
LPCAT3
0.010 Biomarker group BEFREE Association between the C3F gene and atherosclerotic vascular diseases. 1184013 1975
Entrez Id: 8517
Gene Symbol: IKBKG
IKBKG
0.010 Biomarker group BEFREE Incontinentia pigmenti should be considered in the differential diagnosis of retinal vascular disease in girls and women of any age. 1267651 1976
Entrez Id: 5340
Gene Symbol: PLG
PLG
0.070 Biomarker group BEFREE Augmentation of synthesis of plasminogen activator inhibitor type 1 by insulin and insulin-like growth factor type I: implications for vascular disease in hyperinsulinemic states. 1719559 1991
Entrez Id: 348
Gene Symbol: APOE
APOE
0.100 GeneticVariation group BEFREE To determine the influence of the apolipoprotein E polymorphism on the occurrence of coronary artery disease (CAD) and on serum lipids, lipoproteins and apolipoproteins we studied 145 patients with angiographically defined CAD and compared them with 153 control subjects without history or complaints of vascular disease and with 35 subjects without significant stenosis on coronary arteriography. 1947727 1991
Entrez Id: 10153
Gene Symbol: CEBPZ
CEBPZ
0.010 Biomarker group BEFREE SPECT can show the effect of amyloid deposits on CBF before the angiopathy causes clinical symptoms. 2398939 1990
Entrez Id: 846
Gene Symbol: CASR
CASR
0.010 GeneticVariation group BEFREE Because of the age-specific effect, the onset of the sickle vasculopathy is delayed by nearly 20 years in the Sen/Ben patient with increased G gamma HbF as compared to those with a CAR haplotype or the homozygous Benin. 2476064 1989
Entrez Id: 6687
Gene Symbol: SPG7
SPG7
0.010 GeneticVariation group BEFREE Because of the age-specific effect, the onset of the sickle vasculopathy is delayed by nearly 20 years in the Sen/Ben patient with increased G gamma HbF as compared to those with a CAR haplotype or the homozygous Benin. 2476064 1989
Entrez Id: 1525
Gene Symbol: CXADR
CXADR
0.010 GeneticVariation group BEFREE Because of the age-specific effect, the onset of the sickle vasculopathy is delayed by nearly 20 years in the Sen/Ben patient with increased G gamma HbF as compared to those with a CAR haplotype or the homozygous Benin. 2476064 1989
Entrez Id: 407
Gene Symbol: ARR3
ARR3
0.010 GeneticVariation group BEFREE Because of the age-specific effect, the onset of the sickle vasculopathy is delayed by nearly 20 years in the Sen/Ben patient with increased G gamma HbF as compared to those with a CAR haplotype or the homozygous Benin. 2476064 1989
Entrez Id: 653108
Gene Symbol: CXADRP1
CXADRP1
0.010 GeneticVariation group BEFREE Because of the age-specific effect, the onset of the sickle vasculopathy is delayed by nearly 20 years in the Sen/Ben patient with increased G gamma HbF as compared to those with a CAR haplotype or the homozygous Benin. 2476064 1989
Entrez Id: 5573
Gene Symbol: PRKAR1A
PRKAR1A
0.010 GeneticVariation group BEFREE Because of the age-specific effect, the onset of the sickle vasculopathy is delayed by nearly 20 years in the Sen/Ben patient with increased G gamma HbF as compared to those with a CAR haplotype or the homozygous Benin. 2476064 1989
Entrez Id: 10206
Gene Symbol: TRIM13
TRIM13
0.010 GeneticVariation group BEFREE Because of the age-specific effect, the onset of the sickle vasculopathy is delayed by nearly 20 years in the Sen/Ben patient with increased G gamma HbF as compared to those with a CAR haplotype or the homozygous Benin. 2476064 1989
Entrez Id: 9970
Gene Symbol: NR1I3
NR1I3
0.010 GeneticVariation group BEFREE Because of the age-specific effect, the onset of the sickle vasculopathy is delayed by nearly 20 years in the Sen/Ben patient with increased G gamma HbF as compared to those with a CAR haplotype or the homozygous Benin. 2476064 1989
Entrez Id: 348
Gene Symbol: APOE
APOE
0.100 GeneticVariation group BEFREE Apo E polymorphism did not make a significant contribution to multiple logistic regression models designed to identify the factors associated with the occurrence of vascular disease in diabetic patients. 7497860 1995
Entrez Id: 4524
Gene Symbol: MTHFR
MTHFR
0.400 GeneticVariation group BEFREE A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase. 7647779 1995
Entrez Id: 348
Gene Symbol: APOE
APOE
0.100 AlteredExpression group BEFREE Explanations for familial stroke aggregation include differential phenotypic expression of apolipoprotein (a) and apolipoprotein E, racial variations in the distribution of vascular disease, identification of the autosomal-dominant disorder cerebral autosomal-dominant arteriopathy with subcortical infarcts and leukoencephalopathy, specific point mutations in the mitochondrial-related disorders, and identification of the clinical significance of hereditable coagulopathies. 7749512 1995
Entrez Id: 4018
Gene Symbol: LPA
LPA
0.070 AlteredExpression group BEFREE Explanations for familial stroke aggregation include differential phenotypic expression of apolipoprotein (a) and apolipoprotein E, racial variations in the distribution of vascular disease, identification of the autosomal-dominant disorder cerebral autosomal-dominant arteriopathy with subcortical infarcts and leukoencephalopathy, specific point mutations in the mitochondrial-related disorders, and identification of the clinical significance of hereditable coagulopathies. 7749512 1995
Entrez Id: 5054
Gene Symbol: SERPINE1
SERPINE1
0.100 AlteredExpression group BEFREE Increased levels of PAI-1 have been associated with vascular disease such as thrombosis and atherosclerosis. 7900096 1994
Entrez Id: 5340
Gene Symbol: PLG
PLG
0.070 AlteredExpression group BEFREE Modulation of expression of monocyte/macrophage plasminogen activator activity and its implications for attenuation of vasculopathy. 7923681 1994
Entrez Id: 7157
Gene Symbol: TP53
TP53
0.020 Biomarker group BEFREE From the standpoint of a clinically useful primary tumor risk factor for predicting occult disease, vascular invasion by the tumor and percentage of embryonal carcinoma component in the tumor are more useful than P53 immunohistochemistry. 8015085 1994
Entrez Id: 213
Gene Symbol: ALB
ALB
0.040 Biomarker group BEFREE Associations of urinary albumin excretion rate with vascular disease in europid nondiabetic subjects. 8086657 1994
Entrez Id: 5340
Gene Symbol: PLG
PLG
0.070 Biomarker group BEFREE Augmentation of the synthesis of plasminogen activator inhibitor type-1 by precursors of insulin. A potential risk factor for vascular disease. 8281664 1994
Entrez Id: 1636
Gene Symbol: ACE
ACE
0.100 GeneticVariation group BEFREE There is evidence that an allelic variation in the angiotensin-converting enzyme (ACE) gene may confer an increased risk of vascular disease. 8610309 1996
Entrez Id: 7039
Gene Symbol: TGFA
TGFA
0.020 Biomarker group BEFREE For example, using PBMCs as stimulators, obtained 6 months posttransplant from CAV+ patients, increases in HAEC-derived PDGF-A chain (31 +/- 7 to 69 +/- 11), TGF-alpha (97 +/- 27 to 201 +/- 23), and HB-EGF (78 +/- 16 to 173 +/- 27) mRNA were demonstrated (all P<0.05 or greater using HPLC peak area as units). 8623164 1996
Entrez Id: 348
Gene Symbol: APOE
APOE
0.100 AlteredExpression group BEFREE Soluble amyloid beta-protein and apolipoprotein E levels in CSF were significantly lower in patients with congophilic angiopathy than in those without angiopathy. 8639071 1996